Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
03/2000
03/28/2000CA2143000C Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
03/28/2000CA2109625C 3,5,3'-triiodothyronine receptor ligands
03/28/2000CA2056662C Naphthoic acid derivative
03/26/2000CA2403011A1 Apparatus for electrical moxibustion using the extract
03/26/2000CA2283350A1 Method of preparing pharmaceutical artemisia extract and apparatus for electrical moxibustion using the extract
03/23/2000WO2000015806A1 Atp synthase subunit homolog
03/23/2000WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
03/23/2000WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same
03/23/2000WO2000015773A2 Inhibition of oncogene transcription by synthetic polyamides
03/23/2000WO2000015770A2 Human serine/threonine protein kinases
03/23/2000WO2000015658A1 FACTOR VIIa INHIBITORS
03/23/2000WO2000015649A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130
03/23/2000WO2000015639A1 Carboline derivatives as cgmp phosphodiesterase inhibitors
03/23/2000WO2000015636A1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists
03/23/2000WO2000015612A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000WO2000015246A2 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000WO2000015245A2 Stable liquid formulations of botulinum toxin
03/23/2000WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor
03/23/2000WO2000015242A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES
03/23/2000WO2000015233A1 Compositions for the treatment of male erectile dysfunction
03/23/2000WO2000015232A1 Taurolidine and/or taurultam against infectious ulcer or gastritis
03/23/2000WO2000015230A1 METHOD FOR TREATING ATHEROSCLEROSIS EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015229A1 METHOD FOR TREATING DIABETES EMPLOYING AN aP2 INHIBITOR AND COMBINATION
03/23/2000WO2000015228A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents
03/23/2000WO2000015222A1 FUSED PYRIDINE INHIBITORS OF cGMP PHOSPHODIESTERASE
03/23/2000WO2000015220A1 A new composition
03/23/2000WO2000015219A1 A new composition
03/23/2000WO2000015218A1 A new composition
03/23/2000WO2000015216A1 Therapeutic compositions (ii)
03/23/2000WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF
03/23/2000WO2000015209A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES
03/23/2000WO2000015208A2 New use of immunosupressants for mmp-mediated diseases
03/23/2000WO2000015204A2 Use of benzenesulfonyl(thio)ureas for the treatment and prophylaxis of dysfunctions of the autonomous nervous system and use of benzenesulfonyl(thio)ureas in combination with beta-receptor blockers
03/23/2000WO2000015196A1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative
03/23/2000WO2000015195A1 Quick release pharmaceutical compositions of drug substances
03/23/2000WO2000015188A1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution)
03/23/2000WO2000006135A3 Cholinergic agents in the treatment of presbyopia
03/23/2000WO2000003244A9 Immortalized human keratinocyte cell line
03/23/2000WO2000000599A3 Composition for the induction of apoptosis in target cells
03/23/2000WO2000000198A8 Piperidine derivatives having effects on serotonin related systems
03/23/2000WO1999066948A3 Use of a dipeptide for stimulating repair processes
03/23/2000WO1999065493A9 Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects
03/23/2000WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS
03/23/2000WO1999061418A3 1α-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000WO1998015272A8 Method for inhibiting stress-activated protein kinases
03/23/2000WO1996040039A3 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications
03/23/2000DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor
03/23/2000CA2344654A1 Regulation of her2/neu oncogene expression by synthetic polyamines
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/23/2000CA2344151A1 Pharmaceutical preparation
03/23/2000CA2344048A1 Factor viia inhibitors
03/23/2000CA2343838A1 Atp synthase subunit homolog
03/23/2000CA2343578A1 Human serine/threonine protein kinases
03/23/2000CA2342585A1 A new composition
03/23/2000CA2342583A1 Fused pyridine inhibitors of cgmp phosphodiesterase
03/23/2000CA2342341A1 A new composition
03/23/2000CA2342278A1 Inhibition of oncogene transcription by synthetic polyamides
03/23/2000CA2342243A1 Stable liquid formulations of botulinum toxin
03/23/2000CA2342233A1 A new composition
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000CA2341155A1 Genes encoding for the human and murine death inducer-obliterator-1
03/23/2000CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987274A1 Factor VIIa Inhibitors
03/22/2000EP0987263A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
03/22/2000EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
03/22/2000EP0986646A1 Ubiquitin conjugation proteins
03/22/2000EP0986644A1 Production of erythropoietin by endogenous gene activation
03/22/2000EP0986574A1 11$g(b)-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones
03/22/2000EP0986562A1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
03/22/2000EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction
03/22/2000EP0986558A2 Ergoline derivatives and their use as somatostatin receptor antagonists
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986555A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
03/22/2000EP0986554A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
03/22/2000EP0986553A1 Dihydropyrimidone derivatives as npy antagonists
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
03/22/2000EP0986539A1 Dna-binding pyrrole and imidazole polyamide derivatives
03/22/2000EP0986530A1 Indane compounds and their pharmaceutical use
03/22/2000EP0986400A1 Integrin ligand, human mindin
03/22/2000EP0986398A1 Method for the production of vaccines against cell surface proteins
03/22/2000EP0986396A1 Prion protein modulator factor (ppmf) and prion resistant animals
03/22/2000EP0986395A1 Peptide parathyroid hormone analogs
03/22/2000EP0986391A1 Oxyalkylene phosphate compounds and uses thereof
03/22/2000EP0986390A1 Pharmaceutical compositions containing cinchonine dichlorhydrate
03/22/2000EP0986389A1 Novel process
03/22/2000EP0986387A1 FARNESYL TRANSFERASE INHIBITORS IN COMBINATION WITH HMG CoA REDUCTASE INHIBITORS FOR THE TREATMENT OF CANCER
03/22/2000EP0986386A2 Use of nitrogen heterocyclic aromatic derivatives in the topical treatment of the epithelial tissues diseases
03/22/2000EP0986385A1 Antagonists of gonadotropin releasing hormone
1 ... 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 ... 1564